BAX Baxter International Inc

$18.30

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 11/21/2025

About Baxter International Inc

Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.

Website: https://www.baxter.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
10456
Address
ONE BAXTER PKWY, DF2-1W, DEERFIELD, IL, US
Valuation
Market Cap
$14.82B
P/E Ratio
nan
PEG Ratio
1.88
Price to Book
2.13
Performance
EPS
$-0.64
Dividend Yield
2.35%
Profit Margin
-6.10%
ROE
-4.21%
Technicals
50D MA
$32.56
200D MA
$34.09
52W High
$40.11
52W Low
$26.25
Fundamentals
Shares Outstanding
513M
Target Price
$39.74
Beta
0.65

BAX EPS Estimates vs Actual

Estimated
Actual

BAX News & Sentiment

Nov 21, 2025 • Benzinga NEUTRAL
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX - Baxter Intl ( NYSE:BAX )
NEW YORK, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. ( NYSE:BAX ) between February 23, 2022 and July 30, 2025, both dates inclusive ( the "Class Period" ) , of the important ...
Nov 20, 2025 • Benzinga NEUTRAL
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit - BAX - Baxter Intl ( NYSE:BAX )
NEW YORK, Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ( "Baxter International, Inc." or the "Company" ) ( NYSE:BAX ) of a class action securities lawsuit.
Nov 20, 2025 • Benzinga NEUTRAL
DEADLINE ALERT for ATYR, MLTX, BAX, JHX: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions - aTyr Pharma ( NASDAQ:ATYR ) , Baxter Intl ( NYSE:BAX )
BENSALEM, Pa., Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Nov 20, 2025 • Benzinga NEUTRAL
BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Baxter Intl ( NYSE:BAX )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options
Nov 19, 2025 • Benzinga SOMEWHAT-BEARISH
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Baxter International, Inc. ( BAX ) Shareholders - Baxter Intl ( NYSE:BAX )
NEW YORK, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. ( NYSE:BAX ) . Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead ...
Nov 18, 2025 • Benzinga SOMEWHAT-BEARISH
Bragar Eagel & Squire, P.C. Urges Stockholders of James Hardie, Baxter, Avantor, and Wildermuth Fund to Contact the Firm Before Upcoming Deadlines - Baxter Intl ( NYSE:BAX ) , Avantor ( NYSE:AVTR )
NEW YORK, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of James Hardie Industries plc ( NYSE:JHX ) , Baxter International, Inc. ( NYSE:BAX ) ...
Sentiment Snapshot

Average Sentiment Score:

-0.146
50 articles with scored sentiment

Overall Sentiment:

Neutral

BAX Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
-0.02 Surprise
  • Reported EPS: $0.59
  • Estimate: $0.61
  • Whisper:
  • Surprise %: -3.3%
May 01, 2025
Mar 31, 2025 (Pre market)
0.07 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.48
  • Whisper:
  • Surprise %: 13.8%
Feb 20, 2025
Dec 31, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $0.58
  • Estimate: $0.52
  • Whisper:
  • Surprise %: 11.5%
Nov 08, 2024
Sep 30, 2024 (Pre market)
-0.29 Surprise
  • Reported EPS: $0.49
  • Estimate: $0.78
  • Whisper:
  • Surprise %: -37.2%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.68
  • Estimate: $0.66
  • Whisper:
  • Surprise %: 3.0%
May 02, 2024
Mar 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.65
  • Estimate: $0.61
  • Whisper:
  • Surprise %: 6.6%
Feb 08, 2024
Dec 31, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.88
  • Estimate: $0.86
  • Whisper:
  • Surprise %: 2.3%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.68
  • Estimate: $0.67
  • Whisper:
  • Surprise %: 1.5%
Jul 27, 2023
Jun 30, 2023 (Pre market)
-0.06 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.61
  • Whisper:
  • Surprise %: -9.8%

Financials